Regulation & Compliance

An international team receives a major grant to use artificial intelligence to predict survival and treatment response, offering new hope for a deadly disease.

FinTech leader Derivative Path promotes Zack Nagelberg to President, signaling a strategic push into AI-driven risk management for evolving capital markets.

The cannabis giant's landmark debt deal signals new institutional confidence, but a high interest rate reveals the industry's costly reality.

Reunion Neuroscience hits the investor conference circuit, seeking capital to advance its groundbreaking psychedelic-inspired therapies for depression and anxiety.

Fractal's new healthcare AI has surpassed leading models from OpenAI and Google, signaling a major leap for India's sovereign AI ambitions and public health.

The mobile health firm now reaches 25 states with its tech-driven model, aiming to close care gaps and answer federal critics of in-home assessments.

A new partnership between WELL Health and HEALWELL AI uses artificial intelligence to find trial participants, but puts patient consent at the forefront.

As Signet prepares its Q4 earnings, all eyes are on whether its brand power can overcome cautious consumer spending and set the tone for the luxury market.

An advocacy group challenges the University of Denver's animal-law program, demanding proof of impact and raising questions about donor funds.

With BRINSUPRI revenues set to hit $1B, Insmed is pouring cash into a high-stakes pipeline. Can it outrun its massive burn rate to deliver the next breakthrough?

The insurer's full-year income soared 56% on strategic shifts, but declining premiums and a weaker Q4 highlight the challenges of its long-term plan.

Early data on YOLT-202 shows it can safely restore normal protein levels in patients with Alpha-1 Antitrypsin Deficiency, a major step toward a cure.

Serina Therapeutics enrolls the first patient in a trial for SER-252, a novel Parkinson's therapy designed to improve symptoms without current side effects.

A new report reveals a shocking spike in evasive malware, with 96% hidden in encrypted traffic, forcing a radical security rethink for businesses.

The insurtech firm posted massive revenue growth driven by its AI platform, but one-time IPO costs obscure the full strength of its 2025 performance.

Caesarstone will release its 2025 results without a conference call, a move raising investor questions amid a year of losses and strategic overhaul.

With COVID revenue fading, QuidelOrtho will use a key conference to prove its diversified diagnostics model can deliver on growth, margins, and cash flow.

A $3.5T financial giant partners with a Trump-linked DeFi firm to integrate stablecoins and tokenize real estate, bridging the gap between TradFi and crypto.

A new AI tool aims to slash errors in critical Medicare documents, promising huge savings for health plans and clearer information for millions of members.

A major expansion by MAX Surgical Specialty Management adds three top oral surgeons, signaling a strategic shift in New Jersey's healthcare landscape.